Medco Will Buy PolyMedica In $1.5 Billion Deal
This article was originally published in The Gray Sheet
Executive Summary
The pharmacy benefit manager Medco is expanding its foothold in the diabetes market with the $1.5 billion purchase of PolyMedica, a direct-to-consumer provider of diabetes supplies and services. The companies announced the definitive all-cash agreement Aug. 28 and expect the deal to close later this year
You may also be interested in...
Final Regulation Establishes Competitive Bidding For Durable Equipment
CMS will require certain medical supply manufacturers to begin submitting pricing bids to Medicare this month under a final 1regulation published April 2
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.